Amarin

Youtube Subscribe

Open: 0.68 Close: 0.68 Change: 0.0

An AI to read internet: The best strategy to evaluate Amarin Company Inc Stock.

This document will help you to evaluate Amarin without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amarin are: Amarin, continue, Press, VASCEPA, VAZKEPA, cash, support, and the …

Concept Map

Semantic Network

Stock Summary

Amarin Corporation plc engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for.

Today's Summary

Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations, including European launch activities. Company continues to deliver significant U.S. sales of VASCEPA and VAZKEPA.

Today's News

Amarin continues to deliver significant U.S. sales of VASCEPA and VAZKEPA. Company continues to make progress on reducing expenses and managing its cash position. Amarin will host a conference call on November 1, 2023, at 8:00 a.m. Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations, including European launch activities. Amarin: Q3 Earnings Snapshot The A.V. (icosapent ethyl) is amarins first fda approved product and is available in the united states by prescription. Cardiovascular disease is the leading cause of death in Spain, according to figures shared by Amarin. Development comes about a week after Amarin said it would lay off about 120 staffers. Amarin Corporation plc (NASDAQ:AMRN) stock price, quote & news - stock analysis. Analyst Consensus: Sell Stock Forecasts News All Videos Press Press Press Releases Conversation Amarin Reports Third Quarter 2023 Financial Results. Amarin to Present at Two Upcoming Investor Conferences. Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China. Amarin announces new supported and/or funded research from the landmark REDUCE-IT cardiovascular outcomes trial on the effects of VASCEPA ® /VAZKEPA (icosapent ethyl) in a specific patient subgroups at increased risk of a cardiovascular (CV) event has been accepted for presentation at the American Heart Association Scientific Sessions 2023.

Stock Profile

"Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Amarin? Investor spend a lot of time searching for information to make investment decisions in Amarin. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amarin are: Amarin, continue, Press, VASCEPA, VAZKEPA, cash, support, and the most common words in the summary are: amarin, report, corporation, amrn, company, new, market, . One of the sentences in the summary was: sales of VASCEPA and VAZKEPA.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amarin #report #corporation #amrn #company #new #market.

Read more →

Youtube Subscribe

---